Skip to content

Insider · CIK 0001771814

Jeffrey Bluestone

director

Files at GILD (GILEAD SCIENCES, INC.). First filing Nov 27, 2024, latest Nov 27, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $620k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

GILD: GILEAD SCIENCES, INC.

GILDOct 9, 2026 · close 151.17

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
45Moderate
GILDsell 3
GILEAD SCIENCES, INC.
$620k
6,788 shares
-43%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 7, 2025GILD
GILEAD SCIENCES, INC.
AGrant or award
Restricted Stock Unitderivative
+1,516$0.00$05,713May 8, 2025
May 7, 2025GILD
GILEAD SCIENCES, INC.
AGrant or award
Non-qualified Stock Option (Right to Buy)derivative
+6,809$0.00$06,809May 8, 2025
Nov 26, 2024GILD
GILEAD SCIENCES, INC.
MOption exercise
Common Stock
+5,879$61.17$360k11,587Nov 27, 2024
Nov 26, 2024GILD
GILEAD SCIENCES, INC.
MOption exercise
Common Stock
+4,121$61.35$253k15,708Nov 27, 2024
Nov 26, 2024GILD
GILEAD SCIENCES, INC.
SOpen-market sale
Common Stock
-6,788$91.39$620k8,920Nov 27, 2024
Nov 26, 2024GILD
GILEAD SCIENCES, INC.
MOption exercise
Non-qualified Stock Option (Right to Buy)derivative
-5,879$0.00$00Nov 27, 2024
Nov 26, 2024GILD
GILEAD SCIENCES, INC.
MOption exercise
Non-qualified Stock Option (Right to Buy)derivative
-4,121$0.00$011,730Nov 27, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jeffrey Bluestone: insider trades and track record | InsiderTell